Article (Scientific journals)
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study
Amadori, Sergio; Suciu, Stefan; Jehn, Ulrich et al.
2005In Blood, 106, p. 27-34
Peer Reviewed verified by ORBi
 

Files


Full Text
214.pdf
Publisher postprint (284.05 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Hematology
Author, co-author :
Amadori, Sergio
Suciu, Stefan
Jehn, Ulrich
Stasi, Roberto
Thomas, Xavier
Marie, Jean-Pierre
Muus, Petra
Lefrère, François
Berneman, Zwi
Fillet, Georges ;  Université de Liège - ULiège > Département des sciences cliniques > Hématologie - Oncologie médicale
Denzlinger, Claudio
Willemze, Roel
Leoni, Pietro
Leone, Giuseppe
Casini, Marco
Ricciuti, Francesco
Vignetti, Marco
Beeldens, Filip
Mandelli, Franco
de Witte, Theo
More authors (10 more) Less
Language :
English
Title :
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia : final results of AML-13, a randomized phase-3 study
Publication date :
2005
Journal title :
Blood
ISSN :
0006-4971
eISSN :
1528-0020
Publisher :
American Society of Hematology, Washington, United States - District of Columbia
Volume :
106
Pages :
27-34
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 07 May 2009

Statistics


Number of views
97 (4 by ULiège)
Number of downloads
679 (0 by ULiège)

Scopus citations®
 
137
Scopus citations®
without self-citations
104
OpenCitations
 
115

Bibliography


Similar publications



Contact ORBi